b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="phenaturepg" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2577677/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577677/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="BMC Infectious Diseases" /><meta name="citation_title" content="Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study" /><meta name="citation_authors" content="C\xc3\xa9dric Daubin, Jean-Jacques Parienti, Astrid Vabret, Michel Ramakers, Sabine Fradin, Nicolas Terzi, Fran\xc3\xa7ois Freymuth, Pierre Charbonneau, Damien du Cheyron" /><meta name="citation_date" content="2008" /><meta name="citation_volume" content="8" /><meta name="citation_doi" content="10.1186/1471-2334-8-145" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2577677/?report=abstract" /><meta name="citation_pmid" content="18947382" /><meta name="DC.Title" content="Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="C\xc3\xa9dric Daubin" /><meta name="DC.Contributor" content="Jean-Jacques Parienti" /><meta name="DC.Contributor" content="Astrid Vabret" /><meta name="DC.Contributor" content="Michel Ramakers" /><meta name="DC.Contributor" content="Sabine Fradin" /><meta name="DC.Contributor" content="Nicolas Terzi" /><meta name="DC.Contributor" content="Fran\xc3\xa7ois Freymuth" /><meta name="DC.Contributor" content="Pierre Charbonneau" /><meta name="DC.Contributor" content="Damien du Cheyron" /><meta name="DC.Date" content="2008" /><meta name="DC.Identifier" content="10.1186/1471-2334-8-145" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study" /><meta property="og:type" content="article" /><meta property="og:description" content="Antibiotics are recommended for severe acute exacerbation of chronic obstructive pulmonary disease (AECOPD) admitted to intensive care units (ICU). Serum procalcitonin (PCT) could be a useful tool for selecting patients with a lower probability of developing ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577677/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-phenaturepg.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2577677/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2577677/pdf/12879_2008_Article_736.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1BD1AEE99B0B410000000003260326.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=Nature%20Public%20Health%20Emergency%20Collection[filter]" class="navlink">Nature Public Health Emergency Collection</a></li><li class="accid">PMC2577677</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div class="banner-generic-logo-background inline_block"><div class="banner-journal-publisher-over-image"><div class="banner-journal-name bl-jtitle-phenaturepg">BMC Infectious Diseases</div><div class="banner-publisher-name">Nature Publishing Group</div></div></div></div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">BMC Infect Dis</span>. 2008; 8: 145. </span></div><div><span class="fm-vol-iss-date">Published online 2008 Oct 23. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2F1471-2334-8-145" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/1471-2334-8-145</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2577677</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/18947382">18947382</a></div></div></div></div><h1 class="content-title">Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Daubin%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18947382" class="affpopup" co-rid="_co_idm139869661209664" co-class="co-affbox">C&#x000e9;dric Daubin</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1</sup> <a href="/pubmed/?term=Parienti%20JJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18947382" class="affpopup" co-rid="_co_idm139869657913856" co-class="co-affbox">Jean-Jacques Parienti</a>,<sup>2</sup> <a href="/pubmed/?term=Vabret%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18947382" class="affpopup" co-rid="_co_idm139869661205904" co-class="co-affbox">Astrid Vabret</a>,<sup>3</sup> <a href="/pubmed/?term=Ramakers%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18947382" class="affpopup" co-rid="_co_idm139869661203536" co-class="co-affbox">Michel Ramakers</a>,<sup>1</sup> <a href="/pubmed/?term=Fradin%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18947382" class="affpopup" co-rid="_co_idm139869658294080" co-class="co-affbox">Sabine Fradin</a>,<sup>4</sup> <a href="/pubmed/?term=Terzi%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18947382" class="affpopup" co-rid="_co_idm139869658291712" co-class="co-affbox">Nicolas Terzi</a>,<sup>1</sup> <a href="/pubmed/?term=Freymuth%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18947382" class="affpopup" co-rid="_co_idm139869658289344" co-class="co-affbox">Fran&#x000e7;ois Freymuth</a>,<sup>2</sup> <a href="/pubmed/?term=Charbonneau%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18947382" class="affpopup" co-rid="_co_idm139869659902304" co-class="co-affbox">Pierre Charbonneau</a>,<sup>1</sup> and  <a href="/pubmed/?term=du%20Cheyron%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18947382" class="affpopup" co-rid="_co_idm139869659899936" co-class="co-affbox">Damien du Cheyron</a><sup>1</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139869661209664"><h3 class="no_margin">C&#x000e9;dric Daubin</h3><p><sup>1</sup>Department of Medical Intensive Care, Caen University Hospital, 14033 Caen Cedex, France </p><div>Find articles by <a href="/pubmed/?term=Daubin%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18947382">C&#x000e9;dric Daubin</a></div></div><div id="_co_idm139869657913856"><h3 class="no_margin">Jean-Jacques Parienti</h3><p><sup>2</sup>Department of Infectious Diseases and Biostatistics and Clinical Research, Caen University Hospital, 14033 Caen Cedex, France </p><div>Find articles by <a href="/pubmed/?term=Parienti%20JJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18947382">Jean-Jacques Parienti</a></div></div><div id="_co_idm139869661205904"><h3 class="no_margin">Astrid Vabret</h3><p><sup>3</sup>Department of Virology, Caen University Hospital, 14033 Caen Cedex, France </p><div>Find articles by <a href="/pubmed/?term=Vabret%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18947382">Astrid Vabret</a></div></div><div id="_co_idm139869661203536"><h3 class="no_margin">Michel Ramakers</h3><p><sup>1</sup>Department of Medical Intensive Care, Caen University Hospital, 14033 Caen Cedex, France </p><div>Find articles by <a href="/pubmed/?term=Ramakers%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18947382">Michel Ramakers</a></div></div><div id="_co_idm139869658294080"><h3 class="no_margin">Sabine Fradin</h3><p><sup>4</sup>Department of Biochemistry, Caen University Hospital, 14033 Caen Cedex, France </p><div>Find articles by <a href="/pubmed/?term=Fradin%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18947382">Sabine Fradin</a></div></div><div id="_co_idm139869658291712"><h3 class="no_margin">Nicolas Terzi</h3><p><sup>1</sup>Department of Medical Intensive Care, Caen University Hospital, 14033 Caen Cedex, France </p><div>Find articles by <a href="/pubmed/?term=Terzi%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18947382">Nicolas Terzi</a></div></div><div id="_co_idm139869658289344"><h3 class="no_margin">Fran&#x000e7;ois Freymuth</h3><p><sup>2</sup>Department of Infectious Diseases and Biostatistics and Clinical Research, Caen University Hospital, 14033 Caen Cedex, France </p><div>Find articles by <a href="/pubmed/?term=Freymuth%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18947382">Fran&#x000e7;ois Freymuth</a></div></div><div id="_co_idm139869659902304"><h3 class="no_margin">Pierre Charbonneau</h3><p><sup>1</sup>Department of Medical Intensive Care, Caen University Hospital, 14033 Caen Cedex, France </p><div>Find articles by <a href="/pubmed/?term=Charbonneau%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18947382">Pierre Charbonneau</a></div></div><div id="_co_idm139869659899936"><h3 class="no_margin">Damien du Cheyron</h3><p><sup>1</sup>Department of Medical Intensive Care, Caen University Hospital, 14033 Caen Cedex, France </p><div>Find articles by <a href="/pubmed/?term=du%20Cheyron%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18947382">Damien du Cheyron</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139869657569264_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139869657569264_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139869657569264_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139869657569264_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1"><sup>1</sup>Department of Medical Intensive Care, Caen University Hospital, 14033 Caen Cedex, France </div><div class="fm-affl" lang="en" id="Aff2"><sup>2</sup>Department of Infectious Diseases and Biostatistics and Clinical Research, Caen University Hospital, 14033 Caen Cedex, France </div><div class="fm-affl" lang="en" id="Aff3"><sup>3</sup>Department of Virology, Caen University Hospital, 14033 Caen Cedex, France </div><div class="fm-affl" lang="en" id="Aff4"><sup>4</sup>Department of Biochemistry, Caen University Hospital, 14033 Caen Cedex, France </div><div><span class="fm-affl">C&#x000e9;dric Daubin, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.neac-uhc@c-nibuad" class="oemail">rf.neac-uhc@c-nibuad</a></span>.</div><div><a href="#idm139869657569264aff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139869657569264_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2008 May 26; Accepted 2008 Oct 23.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139869657569264_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Daubin et al; licensee BioMed Central Ltd. 2008</div><div class="license half_rhythm">This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href="http://creativecommons.org/licenses/by/2.0" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/2.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2577677/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p1" class="p p-first-last">Antibiotics are recommended for severe acute exacerbation of chronic obstructive pulmonary disease (AECOPD) admitted to intensive care units (ICU). Serum procalcitonin (PCT) could be a useful tool for selecting patients with a lower probability of developing bacterial infection, but its measurement has not been investigated in this population.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Methods</h3><p id="__p2" class="p p-first-last">We conducted a single center prospective cohort study in consecutive COPD patients admitted to the ICU for AECOPD between September 2005 and September 2006. Sputum samples or tracheal aspirates were tested for the presence of bacteria and viruses. PCT levels were measured at the time of admittance, six hours, and 24 hours using a sensitive immunoassay.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Results</h3><p id="__p3" class="p p-first-last">Thirty nine AECOPD patients were included, 31 of which (79%) required a ventilator support at admission. The median [25%&#x02013;75% interquartile range] PCT level, assessed in 35/39 patients, was: 0.096 &#x003bc;g/L [IQR, 0.065 to 0.178] at the time of admission, 0.113 &#x003bc;g/L [IQR, 0.074 to 0.548] at six hours, and 0.137 &#x003bc;g/L [IQR, 0.088 to 0.252] at 24 hours. The highest PCT (PCTmax) levels were less than 0.1 &#x003bc;g/L in 14/35 (40%) patients and more than 0.25 &#x003bc;g/L in 10/35 (29%) patients, suggesting low and high probability of bacterial infection, respectively. Five species of bacteria and nine species of viruses were detected in 12/39 (31%) patients. Among the four patients positive for <em>Pseudomonas aeruginosa</em>, one had a PCTmax less than 0.25 &#x003bc;g/L and three had a PCTmax less than 0.1 &#x003bc;g/L. The one patient positive for <em>Haemophilus influenzae</em> had a PCTmax more than 0.25 &#x003bc;g/L. The presence or absence of viruses did not influence PCT at time of admission (0.068 vs 0.098 &#x003bc;g/L respectively, <em>P</em> = 0.80).</p></div><div id="__sec4" class="sec"><h3 id="__sec4title">Conclusion</h3><p id="__p4" class="p p-first-last">The likelihood of bacterial infection is low among COPD patients admitted to ICU for AECOPD (40% with PCT &#x0003c; 0.1 &#x003bc;g/L) suggesting a possible inappropriate use of antibiotics. Further studies are necessary to assess the impact of a procalcitonin-based therapeutic strategy in critically ill COPD patients.</p></div><div id="__sec5" class="sec sec-last"><h3 id="__sec5title">Electronic supplementary material</h3><p id="__p5" class="p p-first-last">The online version of this article (doi:10.1186/1471-2334-8-145) contains supplementary material, which is available to authorized users.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease Patient, Intensive Care Unit Admission, Procalcitonin Level, Severe Acute Exacerbation</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Introduction</h2><p id="__p6" class="p p-first">Acute exacerbations are a leading cause of severe respiratory failure in chronic obstructive pulmonary disease (COPD) patients [<a href="#CR1" rid="CR1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069618">1</a>]. In this setting, the use of antibiotics is recommended by the recent guidelines of the European Respiratory Society (ERS), and French Consensus Conference [<a href="#CR2" rid="CR2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069604">2</a>, <a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069622">3</a>]. However, bacteria are isolated from the respiratory tract of only approximately 50% of patients with severe acute exacerbation of COPD (AECOPD) [<a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069640">4</a>&#x02013;<a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069611">6</a>]. Whether this finding represents colonization or infection is controversial [<a href="#CR7" rid="CR7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069654">7</a>&#x02013;<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069615">9</a>]. In contrast, a high prevalence of respiratory viruses has been reported in severe AECOPD requiring ventilation [<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069651">10</a>, <a href="#CR11" rid="CR11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069612">11</a>].</p><p id="__p7">In this context, a rapid, specific test to identify lower respiratory bacterial infections would be a major advancement, limiting the inappropriate use of antibiotics which is considered to be a main cause of the spread of antibiotic-resistant bacteria [<a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069642">12</a>, <a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069648">13</a>]. Serum procalcitonin levels are considered to be one of the best biomarkers for predicting a bacterial infection [<a href="#CR14" rid="CR14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069641">14</a>]. The level of circulating procalcitonin is increased in severe bacterial infections, but remains fairly low in viral infection and non specific inflammatory diseases [<a href="#CR15" rid="CR15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069637">15</a>, <a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069603">16</a>]. In addition, procalcitonin-based therapeutic strategies have been shown to substantially and safely reduce antibiotic use in patients with no severe lower respiratory tract infections [<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069621">17</a>] or acute exacerbation of COPD [<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069646">18</a>]. However, studies that specifically assess this marker in critically ill patients are scarce.</p><p id="__p8" class="p p-last">The aim of the current study was to assess procalcitonin levels in, and their relationship with viruses and bacteria in respiratory samples from COPD patients admitted to the ICU for AECOPD.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Materials and methods</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Patients</h3><p id="__p9" class="p p-first-last">COPD patients with suspected lower respiratory tract infection admitted to the medical intensive care unit of the University Hospital of Caen between September 2005 and September 2006 were assessed for eligibility. Only those with AECOPD were included in the analysis. Patients with the presence of infiltrates on chest radiographs taken at admission and suspected of pneumonia, or exhibiting evidence of other causes of respiratory failure, were not included in this study.</p></div><div id="Sec4" class="sec"><h3 id="Sec4title">Definition</h3><p id="__p10" class="p p-first">We defined COPD according to the Global Initiative for Chronic Obstructive Lung Disease Guidelines (GOLD) 2005 <a href="http://www.goldcopd.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.goldcopd.org</a> as an FEV1/FVC ratio (forced expiratory volume in 1 second/functional vital capacity) of less than 70%, with severity categorized into mild (FEV1 &#x02265; 80% of predicted), moderate (FEV1 &#x02265; 50% to &#x0003c; 80%), severe (FEV1 &#x02265; 30% to &#x0003c; 50%) and very severe (FEV1 &#x0003c; 30%). An AECOPD was defined as "a sustained worsening of patient\'s condition, from stable state and beyond normal day-to-day variations, that is acute in onset and necessitates a change in regular medication in a patient with underlying COPD" [<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069602">19</a>].</p><p id="__p11" class="p p-last">AECOPD was considered bacteriologically confirmed in the presence of a positive Gram stain of respiratory samples, a pathogen concentration greater than 10<sup>5</sup>cfu/mL in tracheobronchial aspirations, or a blood culture revealing a bacterial pathogen in the absence of an extrapulmonary focus [<a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069636">4</a>]. A culture, indirect immunofluorescence assay (IFA) or polymerase chain reaction (PCR) assay positive for viruses was considered evidence for a viral pathogen.</p></div><div id="Sec5" class="sec"><h3 id="Sec5title">Study design</h3><p id="__p12" class="p p-first-last">The protocol of this prospective cohort study was submitted to the local ethics committee. The ethical board decided that approval was not necessary given the observational nature of our study. Thus, according to French legislation at the time of the study, no informed consent was obtained from the patients. Upon admission to the ICU, baseline assessment included the severity of COPD according to GOLD criteria; home oxygen and home non-invasive ventilation treatment; chronic steroid therapy; comorbidities such as cigarette smoking, chronic alcohol abuse, obesity, diabetes mellitus, or chronic cardiovascular diseases; use of antibiotic therapy and oral steroids for exacerbations of COPD during the previous 30-day period; use of antibiotics within 24 hours of ICU admission; physical examination; chest radiography; and routine blood tests including c-reactive protein (CRP) at admission (CRP-H0) and 24 hours later (CRP-H24). In addition, scoring of disease severity the first day in ICU was assessed by the Simplified Acute Physiology Score type II (SAPS II) [<a href="#CR20" rid="CR20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069614">20</a>], the Acute Physiology and Chronic Health Evaluation (APACHE II) score[<a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069625">21</a>], and the Logistic Organ Dysfunction (LOD) score [<a href="#CR22" rid="CR22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069649">22</a>]. All patients were treated according to the recommendations of the French Consensus Conference [<a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069619">3</a>].</p></div><div id="Sec6" class="sec"><h3 id="Sec6title">Measurement of serum procalcitonin</h3><p id="__p13" class="p p-first-last">All blood samples were centrifuged, decanted, aliquoted, and frozen at -80&#x000b0;C until analyzed at the end of the study period. PCT was measured using a sensitive immunoassay (Kryptor PCT, Brahms, Hennigsdorf, Germany) with a functional assay sensitivity of 0.06 &#x003bc;g/L, about fourfold above mean normal levels [<a href="#CR23" rid="CR23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069639">23</a>]. The circulating levels of procalcitonin were sequentially assessed at ICU admission (PCT-H0), after six hours (PCT-H6), and twenty fours (PCT-H24) hours. Patients were classified into three groups based on the probability of bacterial infection according to the highest procalcitonin level measured (PCTmax), as previously reported [<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069628">17</a>, <a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069630">18</a>]: group1 PCTmax &#x0003c; 0.1 &#x003bc;g/L indicating an absence of infection, group 2 PCTmax &#x0003e; 0.1 and &#x0003c; 0.25 &#x003bc;g/L indicating a possible infection and group 3 PCTmax &#x0003e; 0.25 &#x003bc;g/L indicating the presence of infection.</p></div><div id="Sec7" class="sec"><h3 id="Sec7title">Microbiological assessment</h3><p id="__p14" class="p p-first-last">Upon enrollment, spontaneously expectorated sputum samples or tracheal aspirates were obtained for Gram staining and cultures. Bacterial isolation and identification was performed with the use of standard techniques. Sputum or tracheal aspirates were bacteriologically processed if less than 1% of the observed field contained squamous epithelial cells and more than 25 neutrophils were observed [<a href="#CR24" rid="CR24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069635">24</a>]. A serological diagnostic for antibodies to <em>Legionella pneumophila</em> was also performed by indirect immunofluorescence, associated with a detection of <em>Legionella pneumophila</em> serogroup 1 antigen in urine samples. In addition, nasal swab or tracheobronchial aspiration was performed in all patients and tested for viruses. Details of the viral detection methods including culture, indirect immunofluorescence assay (IFA), and molecular methods (PCR or RT-PCR), are published elsewhere [<a href="#CR11" rid="CR11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069616">11</a>, <a href="#CR25" rid="CR25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069644">25</a>&#x02013;<a href="#CR27" rid="CR27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199733">27</a>]. We tested for the following viruses: parainfluenza virus (PIV) 1,2,3, and 4; influenza virus A,B, and C; respiratory syncytial virus (RSV); metapneumovirus (hMPV); rhinovirus (RV); coronavirus 229E and OC43; and, adenovirus (AdV). <em>Chlamydia pneumoniae</em> and <em>Mycoplasma pneumoniae</em> were also detected by PCR assay.</p></div><div id="Sec8" class="sec sec-last"><h3 id="Sec8title">Statistical analysis</h3><p id="__p15" class="p p-first-last">Quantitative and qualitative data were expressed as means (+/- SD), or median [25%&#x02013;75% interquartile range] and percentage (with their 95% CI), respectively. Categorical variables were compared using the chi-square or Fischer\'s exact test as appropriate. Quantitative variables were compared using the Student <em>t</em>-test or the Mann-Whitney non parametric test as appropriate. Confidence intervals of percentages were based on normal approximation. The level of significance was set at 0.05 and all tests were two-sided. We used EPI-INFO version 6.04 dfr (EPI-INFO, CDC, Atlanta, GA) for data collection, and EPI-INFO and SAS version 9.1 (SAS Institute Inc, Cary, NC) for data analysis.</p></div></div><div id="Sec9" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec9title">Results</h2><div id="Sec10" class="sec sec-first"><h3 id="Sec10title">Baseline characteristics</h3><p id="__p16" class="p p-first-last">During the period of the study, 80 COPD patients with suspected lower respiratory tract infection were admitted to the ICU, 39 of which had AECOPD (Figure <a href="/pmc/articles/PMC2577677/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure1).</span></span><span>1</span></a>). Baseline characteristics of the AECOPD patients are shown Table <a href="/pmc/articles/PMC2577677/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1.</span></span><span>1</span></a>. Twenty nine patients (74%) had severe or very severe COPD. Twenty seven (69%) received home oxygen or home non-invasive ventilation. Use of antibiotic therapy or oral steroids for exacerbations of COPD during the previous 30-day period was reported in 13 and 11 patients, respectively. Nine patients had received antibiotics within 24 hours of ICU admission. The following treatments were given at admission: non invasive ventilation (NIV) in 27 (69%) patients; mechanical ventilation in 6 (15%) patients, 2 of whom after NIV failure; antibiotics in 33 (85%) patients; systemic steroids in 30 (77%) patients; and a &#x003b2;<sub>2</sub>-agonist with inhaled steroids in all patients.\n\n</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p17">Baseline characteristics of all patients and according to the maximum procalcitonin levels measured (PCTmax)</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139869652637072" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">AECOPD n = 39*</th><th align="center" rowspan="1" colspan="1">PCTmax&#x0003c;0.1 n = 14</th><th align="center" rowspan="1" colspan="1">0.1&#x0003c;PCTmax&#x0003c;0.25 n = 11</th><th align="center" rowspan="1" colspan="1">PCTmax&#x0003e;0.25 n = 10</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, yr</td><td align="center" rowspan="1" colspan="1">62 &#x000b1; 15</td><td align="center" rowspan="1" colspan="1">54 &#x000b1; 16</td><td align="center" rowspan="1" colspan="1">71 &#x000b1; 10</td><td align="center" rowspan="1" colspan="1">66 &#x000b1; 7</td></tr><tr><td align="left" rowspan="1" colspan="1">Male sex, no.(%)</td><td align="center" rowspan="1" colspan="1">26(67)</td><td align="center" rowspan="1" colspan="1">7(50)</td><td align="center" rowspan="1" colspan="1">8(73)</td><td align="center" rowspan="1" colspan="1">9(90)</td></tr><tr><td align="left" rowspan="1" colspan="1">SAPS II score<sup>&#x000b6;</sup>\n</td><td align="center" rowspan="1" colspan="1">30 [23&#x02013;35]</td><td align="center" rowspan="1" colspan="1">25 [18&#x02013;30]</td><td align="center" rowspan="1" colspan="1">31 [26&#x02013;33]</td><td align="center" rowspan="1" colspan="1">39 [28&#x02013;40]</td></tr><tr><td align="left" rowspan="1" colspan="1">APACHE II score<sup>&#x000b6;&#x000b6;</sup>\n</td><td align="center" rowspan="1" colspan="1">18 [12&#x02013;23]</td><td align="center" rowspan="1" colspan="1">13 [9&#x02013;23]</td><td align="center" rowspan="1" colspan="1">18 [16&#x02013;22]</td><td align="center" rowspan="1" colspan="1">19 [18&#x02013;26]</td></tr><tr><td align="left" rowspan="1" colspan="1">LOD score<sup>&#x000b6;&#x000b6;&#x000b6;</sup>\n</td><td align="center" rowspan="1" colspan="1">4 [2&#x02013;5]</td><td align="center" rowspan="1" colspan="1">3 [2&#x02013;4]</td><td align="center" rowspan="1" colspan="1">4 [2&#x02013;4]</td><td align="center" rowspan="1" colspan="1">5 [3&#x02013;8]</td></tr><tr><td align="left" rowspan="1" colspan="1">Comorbidities, no. (%)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Current smokers,</td><td align="center" rowspan="1" colspan="1">11(28)</td><td align="center" rowspan="1" colspan="1">4(29)</td><td align="center" rowspan="1" colspan="1">4(36)</td><td align="center" rowspan="1" colspan="1">3(30)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Chronic alcohol abuse</td><td align="center" rowspan="1" colspan="1">8(20)</td><td align="center" rowspan="1" colspan="1">3(21)</td><td align="center" rowspan="1" colspan="1">2(18)</td><td align="center" rowspan="1" colspan="1">2(20)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Obesity</td><td align="center" rowspan="1" colspan="1">8(20)</td><td align="center" rowspan="1" colspan="1">2(14)</td><td align="center" rowspan="1" colspan="1">4(36)</td><td align="center" rowspan="1" colspan="1">2(20)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Coronary artery disease</td><td align="center" rowspan="1" colspan="1">4(10)</td><td align="center" rowspan="1" colspan="1">1(7)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3(30)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Hypertensive heart disease</td><td align="center" rowspan="1" colspan="1">15(38)</td><td align="center" rowspan="1" colspan="1">4(29)</td><td align="center" rowspan="1" colspan="1">4(36)</td><td align="center" rowspan="1" colspan="1">5(50)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Congestive heart disease</td><td align="center" rowspan="1" colspan="1">2(5)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1(9)</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Diabetes mellitus</td><td align="center" rowspan="1" colspan="1">13(33)</td><td align="center" rowspan="1" colspan="1">6(42)</td><td align="center" rowspan="1" colspan="1">4(36)</td><td align="center" rowspan="1" colspan="1">3(30)</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic Pseudomonas colonization, no. (%)</td><td align="center" rowspan="1" colspan="1">5(13)</td><td align="center" rowspan="1" colspan="1">3(21)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2(20)</td></tr><tr><td align="left" rowspan="1" colspan="1">Severity of COPD<sup>&#x000b6;&#x000b6;&#x000b6;&#x000b6;</sup>, no. (%)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;GOLD stage I (mild)</td><td align="center" rowspan="1" colspan="1">7(18)</td><td align="center" rowspan="1" colspan="1">4(29)</td><td align="center" rowspan="1" colspan="1">1(9)</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;GOLD stage II (moderate)</td><td align="center" rowspan="1" colspan="1">3(8)</td><td align="center" rowspan="1" colspan="1">1(7)</td><td align="center" rowspan="1" colspan="1">2(18)</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;GOLD stage III (sever)</td><td align="center" rowspan="1" colspan="1">3(8)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2(18)</td><td align="center" rowspan="1" colspan="1">1(10)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;GOLD stage IV (very sever)</td><td align="center" rowspan="1" colspan="1">26(67)</td><td align="center" rowspan="1" colspan="1">9(64)</td><td align="center" rowspan="1" colspan="1">6(54)</td><td align="center" rowspan="1" colspan="1">9(90)</td></tr><tr><td align="left" rowspan="1" colspan="1">Home oxygen, no. (%)</td><td align="center" rowspan="1" colspan="1">22(56)</td><td align="center" rowspan="1" colspan="1">8(57)</td><td align="center" rowspan="1" colspan="1">5(45)</td><td align="center" rowspan="1" colspan="1">8(80)</td></tr><tr><td align="left" rowspan="1" colspan="1">Home non-invasive ventilation, no. (%)</td><td align="center" rowspan="1" colspan="1">5(13)</td><td align="center" rowspan="1" colspan="1">2(14)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2(20)</td></tr><tr><td align="left" rowspan="1" colspan="1">Oral or inhaled steroid, no. (%)</td><td align="center" rowspan="1" colspan="1">23(59)</td><td align="center" rowspan="1" colspan="1">8(57)</td><td align="center" rowspan="1" colspan="1">7(64)</td><td align="center" rowspan="1" colspan="1">8(80)</td></tr><tr><td align="left" rowspan="1" colspan="1">Examination at ICU admission, no. (%)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Dyspnea</td><td align="center" rowspan="1" colspan="1">39(100)</td><td align="center" rowspan="1" colspan="1">14(100)</td><td align="center" rowspan="1" colspan="1">11(100)</td><td align="center" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Cough</td><td align="center" rowspan="1" colspan="1">17(44)</td><td align="center" rowspan="1" colspan="1">5(35)</td><td align="center" rowspan="1" colspan="1">8(73)</td><td align="center" rowspan="1" colspan="1">4(40)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Sputum</td><td align="center" rowspan="1" colspan="1">15(33)</td><td align="center" rowspan="1" colspan="1">5(36)</td><td align="center" rowspan="1" colspan="1">5(45)</td><td align="center" rowspan="1" colspan="1">5(50)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Rales</td><td align="center" rowspan="1" colspan="1">4(10)</td><td align="center" rowspan="1" colspan="1">1(7)</td><td align="center" rowspan="1" colspan="1">1(9)</td><td align="center" rowspan="1" colspan="1">2(20)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Wheezing</td><td align="center" rowspan="1" colspan="1">30(77)</td><td align="center" rowspan="1" colspan="1">11(100)</td><td align="center" rowspan="1" colspan="1">10(90)</td><td align="center" rowspan="1" colspan="1">7(70)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Body temperature,&#x000b0;C</td><td align="center" rowspan="1" colspan="1">37.0 &#x000b1; 0.8</td><td align="center" rowspan="1" colspan="1">36.7 &#x000b1; 0.9</td><td align="center" rowspan="1" colspan="1">37.2 &#x000b1; 0.5</td><td align="center" rowspan="1" colspan="1">37.2 &#x000b1; 0.8</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Leucocytes count ((&#x000d7;10<sup>9</sup>/L)</td><td align="center" rowspan="1" colspan="1">11.5 &#x000b1; 4.3</td><td align="center" rowspan="1" colspan="1">9.3 &#x000b1; 4.1</td><td align="center" rowspan="1" colspan="1">11.2 &#x000b1; 4.6</td><td align="center" rowspan="1" colspan="1">14.2 &#x000b1; 2.9</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;CRP-H0</td><td align="center" rowspan="1" colspan="1">19 [9&#x02013;60]</td><td align="center" rowspan="1" colspan="1">13 [8&#x02013;22]</td><td align="center" rowspan="1" colspan="1">15 [5&#x02013;66]</td><td align="center" rowspan="1" colspan="1">43 [11&#x02013;156]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;CRP-H24</td><td align="center" rowspan="1" colspan="1">21 [11&#x02013;34]</td><td align="center" rowspan="1" colspan="1">21 [11&#x02013;24]</td><td align="center" rowspan="1" colspan="1">17 [9&#x02013;32]</td><td align="center" rowspan="1" colspan="1">78 [11&#x02013;106]</td></tr></tbody></table></div><div id="largeobj_idm139869652637072" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2577677/table/Tab1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p18">Values are given as No.(%), median [25%&#x02013;75% interquartile range], or mean &#x000b1; standard deviation</p><p id="__p19">* Levels of procalcitonin (PCT) were assessed in 35/39 patients. PCT is given in &#x003bc;g/L</p><p id="__p20">&#x000b6; <em>P = 0.005</em> for comparing PCTmax &#x0003e; 0.25 &#x003bc;g/L versus PCTmax &#x0003c; 0.25 &#x003bc;g/L; &#x000b6;&#x000b6; <em>P = 0.08</em> for comparing PCTmax &#x0003e; 0.25 &#x003bc;g/L versus PCTmax &#x0003c; 0.25 &#x003bc;g/L; &#x000b6;&#x000b6;&#x000b6; <em>P = 0.018</em> for comparing PCTmax &#x0003e; 0.25 &#x003bc;g/L versus PCTmax &#x0003c; 0.25 &#x003bc;g/L; &#x000b6;&#x000b6;&#x000b6;&#x000b6; <em>P = 0.07</em> for comparing PCTmax &#x0003e; 0.25 &#x003bc;g/L versus PCTmax &#x0003c; 0.25 &#x003bc;g/L</p></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC2577677/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139869657844624" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12879_2008_Article_736_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12879_2008_Article_736_Fig1_HTML.jpg" src="/pmc/articles/PMC2577677/bin/12879_2008_Article_736_Fig1_HTML.jpg" /></div><div id="largeobj_idm139869657844624" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2577677/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC2577677/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p21">\n<strong>The flow of the study measuring procalcitonin in COPD patients</strong>. * Procalcitonin (PCT) levels were not assessed in 4 patients. ** The arrow indicate cross-over between groups.</p></div></div></div></div><div id="Sec11" class="sec"><h3 id="Sec11title">Laboratory measurements</h3><p id="__p22" class="p p-first-last">The circulating levels of procalcitonin are shown in Figure <a href="/pmc/articles/PMC2577677/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure2.</span></span><span>2</span></a>. The median [25%&#x02013;75% interquartile range] procalcitonin levels at admission (PCT-H0) were 0.096 &#x003bc;g/L [0.065&#x02013;0.178], PCT-H6 was 0.113 &#x003bc;g/L [0.074&#x02013;0.548], and PCT-H24 was 0.137 &#x003bc;g/L [0.088&#x02013;0.252]. Procalcitonin levels were not different in patients who had received antibiotics in the month or the 24 hours prior to ICU admission compared to antibiotic-naive patients (PCT-H0 0.071 &#x003bc;g/L [0.056&#x02013;0.189] vs 0.099 &#x003bc;g/L [0.065&#x02013;0.178], <em>P</em> = 0.36 and PCT-H0 0.081 &#x003bc;g/L [0.071&#x02013;0.397] vs 0.103 &#x003bc;g/L [0.062&#x02013;0.178], <em>P</em> = 0.93, respectively). There was no association between PCT-H0 levels and the presence or absence of sputum (PCT-H0 0.106 &#x003bc;g/L [0.072&#x02013;0.231] vs 0.085 &#x003bc;g/L [0.062&#x02013;0.163], <em>P</em> = 0.65, cough (PCT-H0 0.083 &#x003bc;g/L [0.068&#x02013;0.162] vs 0.103 &#x003bc;g/L [0.062&#x02013;0.695], <em>P</em> = 0.57, wheezing (PCT-H0 0.083 &#x003bc;g/L [0.057&#x02013;0.178] vs 0.103 &#x003bc;g/L [0.075&#x02013;0.695], <em>P</em> = 0.29, and fever (ie temperature &#x0003e; 38&#x000b0;C) (PCT-H0 0.081 &#x003bc;g/L [0.068&#x02013;0.103] vs 0.098 &#x003bc;g/L [0.059&#x02013;0.183], <em>P</em> = 0.92). The PCTmax was &#x0003c; 0.1 &#x003bc;g/L in 14/35 patients (40%), between 0.1 and 0.25 &#x003bc;g/L in 11/35 patients (31%), and &#x0003e; 0.25 &#x003bc;g/L in 10/35 patients (29%). There was no association between the PCTmax levels and the severity of COPD (<em>P</em> = 0.07). Patients with PCTmax &#x0003e; 0.25 &#x003bc;g/L were more critically ill: SAPS II 39 [28&#x02013;40] vs 27 [24&#x02013;31] among patients with PCTmax &#x02264; 0.25 &#x003bc;g/L, <em>P</em> = 0.005 ; and LOD 5 [3&#x02013;8] vs 3 [2&#x02013;4] among patients with PCTmax &#x02264; 0.25 &#x003bc;g/L, <em>P</em> = 0.018. The median CRP level at admission (CRP-H0) was 19 mg/L [9&#x02013;60] and CRP-H24 was 21 mg/L [11&#x02013;34] and was not significantly higher among those with a PCTmax &#x0003e; 0.25 &#x003bc;g/L (CRP-H0 43 &#x003bc;g/L [11&#x02013;156] vs 14 [8&#x02013;24], <em>P</em> = 0.12 and CRP-H24 78 &#x003bc;g/L [11&#x02013;106] vs 20 [11&#x02013;26], <em>P</em> = 0.17).\n</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC2577677/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139869657961200" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12879_2008_Article_736_Fig2_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12879_2008_Article_736_Fig2_HTML.jpg" src="/pmc/articles/PMC2577677/bin/12879_2008_Article_736_Fig2_HTML.jpg" /></div><div id="largeobj_idm139869657961200" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2577677/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC2577677/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p23">\n<strong>Box-and-whisker plots representing PCT levels measured at various time</strong>. On the horizontal axis, and for each boxplot, the legend corresponds to the time of PCT measurement. On the vertical axis, the number corresponds to the PCT levels (&#x003bc;g/L). Each box denotes the middle 50% of the data measured at that time. The lower and upper ends of the box denote the 25<sup>th</sup> and 75<sup>th</sup> percentile, respectively. The solid black horizontal lines through each box denote the median of the distribution. The vertical solid black lines (the "whisker") reach out to the 1.5 interquartile range. Circles above the whisker denote individual external observations.</p></div></div></div></div><div id="Sec12" class="sec"><h3 id="Sec12title">Bacteria and viral findings</h3><p id="__p24" class="p p-first-last">Samples were taken at admission in the form of sputum, tracheobronchial aspirates, or nasal swabs for bacteria and viral studies in 29 (75%) and 34 (87%) patients, respectively, but failed because of technical problems in 10 and 5 patients, respectively. Additionally, hemocultures and <em>Legionella</em> diagnostic tests were performed in 37 (95%) and 38 (97%) patients, respectively. According to our definition, 12 (31%) patients had AECOPD microbiologically confirmed. Five species of bacteria (4 <em>Pseudomonas aeruginosa</em>, 1 <em>Haemophilus influenzae</em>) and 9 species of viruses (6 rhinovirus, 1 human metapneumovirus, 1 parainfluenza 1 and 1 parinfluenza 3) were detected. A co-infection was detected in 2 cases (rhinovirus and <em>Pseudomonas aeruginosa</em>, rhinovirus and <em>Haemophilus influenzae</em>). PCT-H0 levels did not differ between patients with or without AECOPD bacteriologically confirmed (PCT-H0 0.081 &#x003bc;g/L [0.062&#x02013;0.189] vs 0.098 &#x003bc;g/L [0.065&#x02013;0.170], <em>P</em> = 0.75). The four patients with <em>Pseudomonas aeruginosa</em> had a PCTmax &#x0003c; 0.25 &#x003bc;g/L. Three of them were known to be chronically colonized by this germ and had a PCTmax &#x0003c; 0.1 &#x003bc;g/L. A positive-virus respiratory sample did not influence PCT levels at admission (PCT-H0 0.068 &#x003bc;g/L [0.062&#x02013;0.695] vs 0.098 &#x003bc;g/L [I0.065&#x02013;0.163], <em>P</em> = 0.80).</p></div><div id="Sec13" class="sec sec-last"><h3 id="Sec13title">Clinical outcome</h3><p id="__p25" class="p p-first-last">During their ICU stay, non-invasive ventilation or mechanical ventilation were performed in 31 patients (79%). The mean length of non-invasive ventilation, mechanical ventilation, and ICU stay without ventilation in days were 4.33 &#x000b1; 4.54, 2.10 &#x000b1; 5.55, and 2.13 &#x000b1; 1.89, respectively. There was no correlation between these findings and procalcitonin levels (data not shown). The mean length of ICU stay was 9 &#x000b1; 7 days. One patient developed a ventilator-associated pneumonia. He died of COPD-related respiratory failure seven days after ICU discharge. In this patient, the PCT levels increased during the first 24 hours (PCT-H0 0.695 &#x003bc;g/L to PCT-H24 1.388 &#x003bc;g/L). No patient developed septic shock. Thirty five patients were discharged from the hospital. Twelve of these patients (34%) were subsequently hospitalised for AECOPD within 6 months. PCT-H0 and PCTmax were not predictive of recurrence (data not shown). Four patients died, three of COPD-related respiratory failure and one of pneumothorax complicated with cardiac arrest. All had very severe COPD and a PCTmax &#x0003e; 0.25 &#x003bc;g/L. In univariate analysis, a PCT level &#x0003e; 0.25 &#x003bc;g/L was associated with mortality (4/10 vs 0/25 deaths among those with a PCT &#x0003c; 0.25 &#x003bc;g/L, <em>P</em> &#x0003c; 0.006).</p></div></div><div id="Sec14" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec14title">Discussion</h2><p id="__p26" class="p p-first">The present study reports procalcitonin levels in critically ill COPD patients admitted for AECOPD with severe conditions according to the Global Initiative for Chronic Obstructive Lung Disease criteria. In agreement with previous reports [<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069610">17</a>, <a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069655">18</a>], PCT levels (&#x0003c; 0.1 &#x003bc;g/L) could indicate an absence of infection in approximately 40% of patients. In this sub-group, no bacteria, were detected in systematic screening, except <em>Pseudomonas aeruginosa</em> in three patients known to be chronically colonized by this pathogen. These preliminary results may have important implications for investigating procalcitonin-based antibiotic strategies in severe AECOPD.</p><p id="__p27">Our findings differ from previous studies assessing the microbiological pattern of AECOPD [<a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069638">4</a>, <a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069606">6</a>, <a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069620">10</a>, <a href="#CR28" rid="CR28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069613">28</a>&#x02013;<a href="#CR30" rid="CR30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069643">30</a>], which reported a higher prevalence of bacteria, varying from 23% [<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069650">10</a>] to 72% [<a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069634">4</a>]. Differences in inclusion criteria and diagnostic tests in an absence of respiratory samples for bacteria detection in a quarter of our patients may explain this difference. Our rates of virus-positive respiratory samples (23%) was consistent with the 22 to 46% prevalence of respiratory viral infection observed in recent prospective studies using molecular methods and focusing on COPD patients [<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069647">10</a>, <a href="#CR11" rid="CR11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069609">11</a>, <a href="#CR30" rid="CR30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069629">30</a>&#x02013;<a href="#CR32" rid="CR32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199734">32</a>].</p><p id="__p28">We found a PCT level of 0.096 &#x003bc;g/L [0.065&#x02013;0.178] in COPD patients admitted to the ICU for severe AECOPD, consistent with previous studies in this setting (0.096 &#x003bc;g/L [0.070&#x02013;0.200] [<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069633">18</a>]; 0.088 &#x003bc;g/L [0.053&#x02013;0.161] [<a href="#CR33" rid="CR33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069624">33</a>]). However, in these two large prospective cohorts focusing on hospitalized AECOPD, less than 10% of patients were admitted to ICU. According to Stolz et al. [<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069653">18</a>], PCT levels were not different between patients pre-treated with antibiotics and antibiotic-naive patients, and no association was found between PCT levels and clinical symptoms or AECOPD bacteriologically confirmed. In addition, the proportion of patients with particular levels of PCT was in accordance with this previous report, suggesting that a large fraction of patients with low PCT levels (PCTmax &#x0003c; 0.1 &#x003bc;g/L) have a low likelihood of bacterial infection. In this sub-group, only one pathogen, <em>Pseudomonas aeruginosa</em>, was detected in three patients known to be chronically colonized by this germ. Whether this finding represents colonization or infection remains controversial [<a href="#CR7" rid="CR7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069605">7</a>, <a href="#CR32" rid="CR32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199736">32</a>, <a href="#CR34" rid="CR34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069652">34</a>, <a href="#CR35" rid="CR35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069601">35</a>]. This could explain why PCT measurements failed to identify 3 from 5 patients with AECOPD bacteriologically documented in our study. In one case, rhinovirus was isolated in association with <em>Pseudomonas aeruginosa</em>, and was considered as the cause of exacerbation. Moreover, we reported that a lower respiratory tract viral infection did not significantly influence PCT levels in this setting. In addition, despite our small sample size, we were able to demonstrate a significant impact of PCT (PCT &#x0003e; 0.25 &#x003bc;g/L in this cohort) in predicting ICU mortality, as previously reported in studies focusing on septic shock [<a href="#CR36" rid="CR36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069600">36</a>] and ventilator-associated pneumonia [<a href="#CR37" rid="CR37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069632">37</a>].</p><p id="__p29">This study had some limitations. The monocentric design of the study and, the relatively small sample size, as well as the fact that sputum could not be taken in 10 patients (25%) for bacteria detection, may limit the interpretation and relevance of our data. However, PCT assessment was performed in 90% of patients using technology recognized as the most sensitive, and our findings are consistent with those of previous studies [<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069617">17</a>, <a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069608">18</a>]. For this reason, we believe that this study adds useful information about PCT levels in severe AECOPD requiring an ICU stay and the likelihood of bacterial infection.</p><p id="__p30" class="p p-last">The results reported here may have important implications for the design of a randomized controlled trial testing procalcitonin-based antibiotic strategies in severe AECOPD. It has been demonstrated antibiotics have a marginal efficacy in the treatment of AECOPD, except among patients with evidence of bacterial infection or severe exacerbation [<a href="#CR38" rid="CR38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199735">38</a>]. Less than 50% of severe AECOPD may be attributed to bacteria, suggesting the potential for excessive antibiotic use in this setting [<a href="#CR39" rid="CR39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069623">39</a>]. Therefore, serum procalcitonin level may be considered as a useful tool for predicting bacterial infection, and may prove useful for selecting patients with a lower probability of bacterial infection and limit the inappropriate use of antibiotics, specifically in the ICU setting where antibiotic use and the emergence of antimicrobial resistance are highly prevalent [<a href="#CR40" rid="CR40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069607">40</a>]. In this context, we speculate that antibiotic use in the subgroup of severe AECOPD with lower PCT (&#x0003c; 0.1 &#x003bc;g/L), could be reduced as previously reported in studies assessing a procalcitonin-based antibiotic strategy in non-severe lower respiratory tract infection [<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069631">17</a>, <a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844069626">18</a>].</p></div><div id="Sec15" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec15title">Conclusion</h2><p id="__p31" class="p p-first-last">Our results support that 40% of patients admitted to ICU for AECOPD have a low likelihood of bacterial infection and correlates with a PCT less than 0.1 &#x003bc;g/L, suggesting a possible inappropriate use of antibiotics. However, further studies are necessary: to assess the short-term effect of a procalcitonin-based therapeutic strategy in critically ill COPD patients in ICU and secondly, to address the role of antimicrobial agents in COPD patients in the long-term, particularly in patients with low PCT levels and bacteria-positive sputum.</p></div><div id="idm139869654514160" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139869654514160title">Acknowledgements</h2><div class="sec"><p id="__p47">The authors want to thank the nursing staff of the Lemi&#x000e8;re and Babinski units for their important contribution during the conduction of this study. The authors thank BRAHMS (the manufacturer of procalcitonin assay) for providing assay material. This study was funded by an academic unrestricted grant from the Caen C&#x000f4;te de Nacre University hospital.</p></div></div><div id="idm139869654510128" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139869654510128title">Abbreviations</h2><div class="bk-sec"><div><table class="default-table glossary"><tbody><tr><td>AECOPD</td><td>acute exacerbation of chronic obstructive pulmonary disease</td></tr><tr><td>APACHE II</td><td>acute physiology and chronic health evaluation type II</td></tr><tr><td>MICU</td><td>medical intensive care unit</td></tr><tr><td>IFA</td><td>indirect immunofluorescence assay</td></tr><tr><td>LOD</td><td>logistic organ dysfunction system</td></tr><tr><td>PCR</td><td>polymerase chain reaction</td></tr><tr><td>PCT</td><td>procalcitonine</td></tr><tr><td>SAPS II</td><td>simplified acute physiology score II</td></tr></tbody></table></div></div></div><div id="App1" class="tsec sec headless whole_rhythm"><!--/article/back/app-group/app/--><div id="Sec16" class="sec sec-first"><h3 id="Sec16title">Authors&#x02019; original submitted files for images</h3><p id="__p32" class="p p-first-last">Below are the links to the authors&#x02019; original submitted files for images.<span class="sup-box" id="MOESM1"><a href="/pmc/articles/PMC2577677/bin/12879_2008_736_MOESM1_ESM.tiff" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 1</a><sup>(45K, tiff)</sup></span>\n<span class="sup-box" id="MOESM2"><a href="/pmc/articles/PMC2577677/bin/12879_2008_736_MOESM2_ESM.tiff" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 2</a><sup>(50K, tiff)</sup></span>\n</p></div></div><div id="idm139869654517296" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139869654517296title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm139869654517168"><p id="__p43" class="p p-first"><strong>Competing interests</strong></p><p id="__p44" class="p p-last">The authors declare that they have no competing interests.</p></p><p class="fn sec" id="idm139869654515920"><p id="__p45" class="p p-first"><strong>Authors\' contributions</strong></p><p id="__p46" class="p p-last">CD and MR initiated the study, the design, and the experimental protocol. AV and FF performed the virologic assessments. SF performed the PCT measurements. CD and JJP performed the statistical analysis and were involved in the interpretation of the results. CD wrote the manuscript, and JJP, MR, and DDC helped to draft the manuscript. DDC, MR, NT, and PC contributed to the conception and design of the study and revision of the manuscript. All authors read and approved the final manuscript.</p></p></div></div><div id="idm139869657569264aff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139869657569264aff-infotitle">Contributor Information</h2><p><span class="fm-affl">C&#x000e9;dric Daubin, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.neac-uhc@c-nibuad" class="oemail">rf.neac-uhc@c-nibuad</a></span>.</p><p><span class="fm-affl">Jean-Jacques Parienti, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.neac-uhc@jj-itneirap" class="oemail">rf.neac-uhc@jj-itneirap</a></span>.</p><p><span class="fm-affl">Astrid Vabret, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.neac-uhc@a-terbav" class="oemail">rf.neac-uhc@a-terbav</a></span>.</p><p><span class="fm-affl">Michel Ramakers, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.neac-uhc@m-srekamar" class="oemail">rf.neac-uhc@m-srekamar</a></span>.</p><p><span class="fm-affl">Sabine Fradin, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.neac-uhc@s-nidarf" class="oemail">rf.neac-uhc@s-nidarf</a></span>.</p><p><span class="fm-affl">Nicolas Terzi, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.neac-uhc@n-izret" class="oemail">rf.neac-uhc@n-izret</a></span>.</p><p><span class="fm-affl">Fran&#x000e7;ois Freymuth, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.neac-uhc@f-htumyerf" class="oemail">rf.neac-uhc@f-htumyerf</a></span>.</p><p><span class="fm-affl">Pierre Charbonneau, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.neac-uhc@p-uaennobrahc" class="oemail">rf.neac-uhc@p-uaennobrahc</a></span>.</p><p><span class="fm-affl">Damien du Cheyron, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.neac-uhc@d-noryehcud" class="oemail">rf.neac-uhc@d-noryehcud</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. <span><span class="ref-journal">Eur Respir J. </span>2006;<span class="ref-vol">28</span>:523\xe2\x80\x93532. doi: 10.1183/09031936.06.00124605.</span> [<a href="/pubmed/16611654" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1183%2F09031936.06.00124605" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+Respir+J&amp;title=Global+burden+of+COPD:+systematic+review+and+meta-analysis&amp;author=RJ+Halbert&amp;author=JL+Natoli&amp;author=A+Gano&amp;author=E+Badamgarav&amp;author=AS+Buist&amp;volume=28&amp;publication_year=2006&amp;pages=523-532&amp;pmid=16611654&amp;doi=10.1183/09031936.06.00124605&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, Heijden G van der, Verheij TJ, European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases  Guidelines for the management of adult lower respiratory tract infections. <span><span class="ref-journal">Eur Respir J. </span>2005;<span class="ref-vol">26</span>:1138\xe2\x80\x931180. doi: 10.1183/09031936.05.00055705.</span> [<a href="/pubmed/16319346" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1183%2F09031936.05.00055705" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+Respir+J&amp;title=Guidelines+for+the+management+of+adult+lower+respiratory+tract+infections&amp;author=M+Woodhead&amp;author=F+Blasi&amp;author=S+Ewig&amp;author=G+Huchon&amp;author=M+Ieven&amp;volume=26&amp;publication_year=2005&amp;pages=1138-1180&amp;pmid=16319346&amp;doi=10.1183/09031936.05.00055705&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Soci&#x000e9;t&#x000e9; de Pathologie Infectieuse de Langue Fran&#x000e7;aise  [15th consensus conference about management of lower respiratory tract infections in immunocompetent adult] <span><span class="ref-journal">Med Mal Infect. </span>2006;<span class="ref-vol">36</span>:235\xe2\x80\x93244. doi: 10.1016/j.medmal.2006.04.003.</span> [<a href="/pubmed/16967525" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.medmal.2006.04.003" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med+Mal+Infect&amp;title=[15th+consensus+conference+about+management+of+lower+respiratory+tract+infections+in+immunocompetent+adult]&amp;volume=36&amp;publication_year=2006&amp;pages=235-244&amp;pmid=16967525&amp;doi=10.1016/j.medmal.2006.04.003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Soler N, Torres A, Ewig S, Gonzalez J, Celis R, El-Ebiary M, Hernandez C, Rodriguez-Roisin R. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>1998;<span class="ref-vol">157</span>:1498\xe2\x80\x93505. doi: 10.1164/ajrccm.157.5.9711044.</span> [<a href="/pubmed/9603129" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Fajrccm.157.5.9711044" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=Bronchial+microbial+patterns+in+severe+exacerbations+of+chronic+obstructive+pulmonary+disease+(COPD)+requiring+mechanical+ventilation&amp;author=N+Soler&amp;author=A+Torres&amp;author=S+Ewig&amp;author=J+Gonzalez&amp;author=R+Celis&amp;volume=157&amp;publication_year=1998&amp;pages=1498-505&amp;pmid=9603129&amp;doi=10.1164/ajrccm.157.5.9711044&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Fagon JY, Chastre J, Trouillet JL, Domart Y, Dombret MC, Bornet M, Gibert C. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. <span><span class="ref-journal">Am Rev Respir Dis. </span>1990;<span class="ref-vol">142</span>:1004\xe2\x80\x931008. doi: 10.1164/ajrccm/142.5.1004.</span> [<a href="/pubmed/2240819" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Fajrccm%2F142.5.1004" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+Rev+Respir+Dis&amp;title=Characterization+of+distal+bronchial+microflora+during+acute+exacerbation+of+chronic+bronchitis.+Use+of+the+protected+specimen+brush+technique+in+54+mechanically+ventilated+patients&amp;author=JY+Fagon&amp;author=J+Chastre&amp;author=JL+Trouillet&amp;author=Y+Domart&amp;author=MC+Dombret&amp;volume=142&amp;publication_year=1990&amp;pages=1004-1008&amp;pmid=2240819&amp;doi=10.1164/ajrccm/142.5.1004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Ferrer M, Ioanas M, Arancibia F, Marco MA, de la Bellacasa JP, Torres A. Microbial airway colonization is associated with noninvasive ventilation failure in exacerbation of chronic obstructive pulmonary disease. <span><span class="ref-journal">Crit Care Med. </span>2005;<span class="ref-vol">33</span>:2003\xe2\x80\x932009. doi: 10.1097/01.CCM.0000178185.50422.DB.</span> [<a href="/pubmed/16148472" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1097%2F01.CCM.0000178185.50422.DB" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Care+Med&amp;title=Microbial+airway+colonization+is+associated+with+noninvasive+ventilation+failure+in+exacerbation+of+chronic+obstructive+pulmonary+disease&amp;author=M+Ferrer&amp;author=M+Ioanas&amp;author=F+Arancibia&amp;author=MA+Marco&amp;author=JP+de+la+Bellacasa&amp;volume=33&amp;publication_year=2005&amp;pages=2003-2009&amp;pmid=16148472&amp;doi=10.1097/01.CCM.0000178185.50422.DB&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Sethi S, Sethi R, Eschberger K, Lobbins P, Cai X, Grant BJ, Murphy TF. Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>2007;<span class="ref-vol">176</span>:356\xe2\x80\x93361. doi: 10.1164/rccm.200703-417OC.</span> [<a href="/pubmed/17478618" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Frccm.200703-417OC" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=Airway+bacterial+concentrations+and+exacerbations+of+chronic+obstructive+pulmonary+disease&amp;author=S+Sethi&amp;author=R+Sethi&amp;author=K+Eschberger&amp;author=P+Lobbins&amp;author=X+Cai&amp;volume=176&amp;publication_year=2007&amp;pages=356-361&amp;pmid=17478618&amp;doi=10.1164/rccm.200703-417OC&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. <span><span class="ref-journal">Clin Microbiol Rev. </span>2001;<span class="ref-vol">14</span>:336\xe2\x80\x93363. doi: 10.1128/CMR.14.2.336-363.2001.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC88978/">PMC free article</a>]</span> [<a href="/pubmed/11292642" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FCMR.14.2.336-363.2001" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Microbiol+Rev&amp;title=Bacterial+infection+in+chronic+obstructive+pulmonary+disease+in+2000:+a+state-of-the-art+review&amp;author=S+Sethi&amp;author=TF+Murphy&amp;volume=14&amp;publication_year=2001&amp;pages=336-363&amp;pmid=11292642&amp;doi=10.1128/CMR.14.2.336-363.2001&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. <span><span class="ref-journal">Ann Intern Med. </span>1987;<span class="ref-vol">106</span>:196\xe2\x80\x93204. doi: 10.7326/0003-4819-106-2-196.</span> [<a href="/pubmed/3492164" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.7326%2F0003-4819-106-2-196" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Intern+Med&amp;title=Antibiotic+therapy+in+exacerbations+of+chronic+obstructive+pulmonary+disease&amp;author=NR+Anthonisen&amp;author=J+Manfreda&amp;author=CP+Warren&amp;author=ES+Hershfield&amp;author=GK+Harding&amp;volume=106&amp;publication_year=1987&amp;pages=196-204&amp;pmid=3492164&amp;doi=10.7326/0003-4819-106-2-196&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Cameron RJ, de Wit D, Welsh TN, Ferguson J, Grissell TV, Rye PJ. Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation. <span><span class="ref-journal">Intensive Care Med. </span>2006;<span class="ref-vol">32</span>:1022\xe2\x80\x931029. doi: 10.1007/s00134-006-0202-x.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7080063/">PMC free article</a>]</span> [<a href="/pubmed/16791664" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2Fs00134-006-0202-x" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Intensive+Care+Med&amp;title=Virus+infection+in+exacerbations+of+chronic+obstructive+pulmonary+disease+requiring+ventilation&amp;author=RJ+Cameron&amp;author=D+de+Wit&amp;author=TN+Welsh&amp;author=J+Ferguson&amp;author=TV+Grissell&amp;volume=32&amp;publication_year=2006&amp;pages=1022-1029&amp;pmid=16791664&amp;doi=10.1007/s00134-006-0202-x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Daubin C, Parienti JJ, Vincent S, Vabret A, du Cheyron D, Ramakers M, Freymuth F, Charbonneau P. Epidemiology and clinical outcome of virus-positive respiratory samples in ventilated patients: a prospective cohort study. <span><span class="ref-journal">Crit Care. </span>2006;<span class="ref-vol">10</span>:R142. doi: 10.1186/cc5059.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1751045/">PMC free article</a>]</span> [<a href="/pubmed/17022805" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2Fcc5059" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Care&amp;title=Epidemiology+and+clinical+outcome+of+virus-positive+respiratory+samples+in+ventilated+patients:+a+prospective+cohort+study&amp;author=C+Daubin&amp;author=JJ+Parienti&amp;author=S+Vincent&amp;author=A+Vabret&amp;author=D+du+Cheyron&amp;volume=10&amp;publication_year=2006&amp;pages=R142&amp;pmid=17022805&amp;doi=10.1186/cc5059&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Wenzel RP, Wong MT. Managing antibiotic use-impact of infection control. <span><span class="ref-journal">Clin Infect Dis. </span>1999;<span class="ref-vol">28</span>:1126\xe2\x80\x931127. doi: 10.1086/514753.</span> [<a href="/pubmed/10452646" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F514753" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Infect+Dis&amp;title=Managing+antibiotic+use-impact+of+infection+control&amp;author=RP+Wenzel&amp;author=MT+Wong&amp;volume=28&amp;publication_year=1999&amp;pages=1126-1127&amp;pmid=10452646&amp;doi=10.1086/514753&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. <span><span class="ref-journal">N Engl J Med. </span>1999;<span class="ref-vol">341</span>:233\xe2\x80\x93239. doi: 10.1056/NEJM199907223410403.</span> [<a href="/pubmed/10413735" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJM199907223410403" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Decreased+susceptibility+of+Streptococcus+pneumoniae+to+fluoroquinolones+in+Canada.+Canadian+Bacterial+Surveillance+Network&amp;author=DK+Chen&amp;author=A+McGeer&amp;author=JC+de+Azavedo&amp;author=DE+Low&amp;volume=341&amp;publication_year=1999&amp;pages=233-239&amp;pmid=10413735&amp;doi=10.1056/NEJM199907223410403&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. <span><span class="ref-journal">Clin Infect Dis. </span>2004;<span class="ref-vol">39</span>:206\xe2\x80\x93217. doi: 10.1086/421997.</span> [<a href="/pubmed/15307030" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F421997" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Infect+Dis&amp;title=Serum+procalcitonin+and+C-reactive+protein+levels+as+markers+of+bacterial+infection:+a+systematic+review+and+meta-analysis&amp;author=L+Simon&amp;author=F+Gauvin&amp;author=DK+Amre&amp;author=P+Saint-Louis&amp;author=J+Lacroix&amp;volume=39&amp;publication_year=2004&amp;pages=206-217&amp;pmid=15307030&amp;doi=10.1086/421997&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. <span><span class="ref-journal">Lancet. </span>1993;<span class="ref-vol">341</span>:515\xe2\x80\x93518. doi: 10.1016/0140-6736(93)90277-N.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7141580/">PMC free article</a>]</span> [<a href="/pubmed/8094770" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0140-6736(93)90277-N" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=High+serum+procalcitonin+concentrations+in+patients+with+sepsis+and+infection&amp;author=M+Assicot&amp;author=D+Gendrel&amp;author=H+Carsin&amp;author=J+Raymond&amp;author=J+Guilbaud&amp;volume=341&amp;publication_year=1993&amp;pages=515-518&amp;pmid=8094770&amp;doi=10.1016/0140-6736(93)90277-N&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">M&#x000fc;ller B, Becker KL, Sch&#x000e4;chinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. <span><span class="ref-journal">Crit Care Med. </span>2000;<span class="ref-vol">28</span>:977\xe2\x80\x93983. doi: 10.1097/00003246-200004000-00011.</span> [<a href="/pubmed/10809269" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1097%2F00003246-200004000-00011" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Care+Med&amp;title=Calcitonin+precursors+are+reliable+markers+of+sepsis+in+a+medical+intensive+care+unit&amp;author=B+M&#x000fc;ller&amp;author=KL+Becker&amp;author=H+Sch&#x000e4;chinger&amp;author=PR+Rickenbacher&amp;author=PR+Huber&amp;volume=28&amp;publication_year=2000&amp;pages=977-983&amp;pmid=10809269&amp;doi=10.1097/00003246-200004000-00011&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, M&#x000fc;ller B. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. <span><span class="ref-journal">Lancet. </span>2004;<span class="ref-vol">363</span>:600\xe2\x80\x93607. doi: 10.1016/S0140-6736(04)15591-8.</span> [<a href="/pubmed/14987884" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0140-6736(04)15591-8" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Effect+of+procalcitonin-guided+treatment+on+antibiotic+use+and+outcome+in+lower+respiratory+tract+infections:+cluster-randomised,+single-blinded+intervention+trial&amp;author=M+Christ-Crain&amp;author=D+Jaccard-Stolz&amp;author=R+Bingisser&amp;author=MM+Gencay&amp;author=PR+Huber&amp;volume=363&amp;publication_year=2004&amp;pages=600-607&amp;pmid=14987884&amp;doi=10.1016/S0140-6736(04)15591-8&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Stolz D, Christ-Crain M, Bingisser R, Leuppi J, Miedinger D, M&#x000fc;ller C, Huber P, M&#x000fc;ller B, Tamm M. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. <span><span class="ref-journal">Chest. </span>2007;<span class="ref-vol">131</span>:9\xe2\x80\x9319. doi: 10.1378/chest.06-1500.</span> [<a href="/pubmed/17218551" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1378%2Fchest.06-1500" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=Antibiotic+treatment+of+exacerbations+of+COPD:+a+randomized,+controlled+trial+comparing+procalcitonin-guidance+with+standard+therapy&amp;author=D+Stolz&amp;author=M+Christ-Crain&amp;author=R+Bingisser&amp;author=J+Leuppi&amp;author=D+Miedinger&amp;volume=131&amp;publication_year=2007&amp;pages=9-19&amp;pmid=17218551&amp;doi=10.1378/chest.06-1500&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. <span><span class="ref-journal">Chest. </span>2000;<span class="ref-vol">117</span>:398S\xe2\x80\x93401S. doi: 10.1378/chest.117.5_suppl_2.398S.</span> [<a href="/pubmed/10843984" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1378%2Fchest.117.5_suppl_2.398S" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=Toward+a+consensus+definition+for+COPD+exacerbations&amp;author=R+Rodriguez-Roisin&amp;volume=117&amp;publication_year=2000&amp;pages=398S-401S&amp;pmid=10843984&amp;doi=10.1378/chest.117.5_suppl_2.398S&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. <span><span class="ref-journal">Jama. </span>1993;<span class="ref-vol">270</span>:2957\xe2\x80\x932963. doi: 10.1001/jama.1993.03510240069035.</span> [<a href="/pubmed/8254858" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1001%2Fjama.1993.03510240069035" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Jama&amp;title=A+new+Simplified+Acute+Physiology+Score+(SAPS+II)+based+on+a+European/North+American+multicenter+study&amp;author=JR+Le+Gall&amp;author=S+Lemeshow&amp;author=F+Saulnier&amp;volume=270&amp;publication_year=1993&amp;pages=2957-2963&amp;pmid=8254858&amp;doi=10.1001/jama.1993.03510240069035&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. <span><span class="ref-journal">Crit Care Med. </span>1985;<span class="ref-vol">13</span>:818\xe2\x80\x93829. doi: 10.1097/00003246-198510000-00009.</span> [<a href="/pubmed/3928249" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1097%2F00003246-198510000-00009" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Care+Med&amp;title=APACHE+II:+a+severity+of+disease+classification+system&amp;author=WA+Knaus&amp;author=EA+Draper&amp;author=DP+Wagner&amp;author=JE+Zimmerman&amp;volume=13&amp;publication_year=1985&amp;pages=818-829&amp;pmid=3928249&amp;doi=10.1097/00003246-198510000-00009&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Le Gall JR, Klar J, Lemeshow S, Saulnier F, Alberti C, Artigas A, Teres d. The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. <span><span class="ref-journal">Jama. </span>1996;<span class="ref-vol">276</span>:802\xe2\x80\x93810. doi: 10.1001/jama.1996.03540100046027.</span> [<a href="/pubmed/8769590" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1001%2Fjama.1996.03540100046027" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Jama&amp;title=The+Logistic+Organ+Dysfunction+system.+A+new+way+to+assess+organ+dysfunction+in+the+intensive+care+unit.+ICU+Scoring+Group&amp;author=JR+Le+Gall&amp;author=J+Klar&amp;author=S+Lemeshow&amp;author=F+Saulnier&amp;author=C+Alberti&amp;volume=276&amp;publication_year=1996&amp;pages=802-810&amp;pmid=8769590&amp;doi=10.1001/jama.1996.03540100046027&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Nylen E, Muller B, Becker KL, Snider R. The future diagnostic role of procalcitonin levels: the need for improved sensitivity. <span><span class="ref-journal">Clin Infect Dis. </span>2003;<span class="ref-vol">36</span>:823\xe2\x80\x93824. doi: 10.1086/368088.</span> [<a href="/pubmed/12627371" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F368088" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Infect+Dis&amp;title=The+future+diagnostic+role+of+procalcitonin+levels:+the+need+for+improved+sensitivity&amp;author=E+Nylen&amp;author=B+Muller&amp;author=KL+Becker&amp;author=R+Snider&amp;volume=36&amp;publication_year=2003&amp;pages=823-824&amp;pmid=12627371&amp;doi=10.1086/368088&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Murray PR, Washington JA. Microscopic and baceriologic analysis of expectorated sputum. <span><span class="ref-journal">Mayo Clin Proc. </span>1975;<span class="ref-vol">50</span>:339\xe2\x80\x93344.</span> [<a href="/pubmed/1127999" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mayo+Clin+Proc&amp;title=Microscopic+and+baceriologic+analysis+of+expectorated+sputum&amp;author=PR+Murray&amp;author=JA+Washington&amp;volume=50&amp;publication_year=1975&amp;pages=339-344&amp;pmid=1127999&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Daubin C, Vincent S, Vabret A, du Cheyron D, Parienti JJ, Ramakers M, Freymuth F, Charbonneau P. Nosocomial viral ventilator-associated pneumonia in the intensive care unit: a prospective cohort study. <span><span class="ref-journal">Intensive Care Med. </span>2005;<span class="ref-vol">31</span>:1116\xe2\x80\x931122. doi: 10.1007/s00134-005-2706-1.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7079837/">PMC free article</a>]</span> [<a href="/pubmed/15999253" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2Fs00134-005-2706-1" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Intensive+Care+Med&amp;title=Nosocomial+viral+ventilator-associated+pneumonia+in+the+intensive+care+unit:+a+prospective+cohort+study&amp;author=C+Daubin&amp;author=S+Vincent&amp;author=A+Vabret&amp;author=D+du+Cheyron&amp;author=JJ+Parienti&amp;volume=31&amp;publication_year=2005&amp;pages=1116-1122&amp;pmid=15999253&amp;doi=10.1007/s00134-005-2706-1&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Bellau-Pujol S, Vabret A, Legrand L, Dina J, Gouarin S, Petitjean-Lecherbonnier, Pozzetto B, Ginevra C, Freymuth F. Development of three multiplex RT-PCR assays for the detection of 12 respiratory RNA viruses. <span><span class="ref-journal">J Virol Methods. </span>2005;<span class="ref-vol">126</span>:53\xe2\x80\x9363. doi: 10.1016/j.jviromet.2005.01.020.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7112904/">PMC free article</a>]</span> [<a href="/pubmed/15847919" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jviromet.2005.01.020" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol+Methods&amp;title=Development+of+three+multiplex+RT-PCR+assays+for+the+detection+of+12+respiratory+RNA+viruses&amp;author=S+Bellau-Pujol&amp;author=A+Vabret&amp;author=L+Legrand&amp;author=J+Dina&amp;author=S+Gouarin&amp;volume=126&amp;publication_year=2005&amp;pages=53-63&amp;pmid=15847919&amp;doi=10.1016/j.jviromet.2005.01.020&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Freymuth F, Vabret A, Rozenberg F, Dina J, Petitjean J, Gouarin S, Legrand L, Corbet S, Brouard J, Lebon P. Replication of respiratory viruses, particularly influenza virus, rhinovirus, and coronavirus in HuH7 hepatocarcinoma cell line. <span><span class="ref-journal">Med Virol. </span>2005;<span class="ref-vol">77</span>:295\xe2\x80\x93301. doi: 10.1002/jmv.20449.</span> [<a href="/pubmed/16121382" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fjmv.20449" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med+Virol&amp;title=Replication+of+respiratory+viruses,+particularly+influenza+virus,+rhinovirus,+and+coronavirus+in+HuH7+hepatocarcinoma+cell+line&amp;author=F+Freymuth&amp;author=A+Vabret&amp;author=F+Rozenberg&amp;author=J+Dina&amp;author=J+Petitjean&amp;volume=77&amp;publication_year=2005&amp;pages=295-301&amp;doi=10.1002/jmv.20449&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. <span><span class="ref-journal">N Engl J Med. </span>2002;<span class="ref-vol">347</span>:465\xe2\x80\x93471. doi: 10.1056/NEJMoa012561.</span> [<a href="/pubmed/12181400" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMoa012561" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=New+strains+of+bacteria+and+exacerbations+of+chronic+obstructive+pulmonary+disease&amp;author=S+Sethi&amp;author=N+Evans&amp;author=BJ+Grant&amp;author=TF+Murphy&amp;volume=347&amp;publication_year=2002&amp;pages=465-471&amp;pmid=12181400&amp;doi=10.1056/NEJMoa012561&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">Ko FW, Ip M, Chan PK, Fok JP, Chan MC, Ngai JC, Chan DP, Hui DS. A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD. <span><span class="ref-journal">Chest. </span>2007;<span class="ref-vol">131</span>:44\xe2\x80\x9352. doi: 10.1378/chest.06-1355.</span> [<a href="/pubmed/17218555" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1378%2Fchest.06-1355" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=A+1-year+prospective+study+of+the+infectious+etiology+in+patients+hospitalized+with+acute+exacerbations+of+COPD&amp;author=FW+Ko&amp;author=M+Ip&amp;author=PK+Chan&amp;author=JP+Fok&amp;author=MC+Chan&amp;volume=131&amp;publication_year=2007&amp;pages=44-52&amp;pmid=17218555&amp;doi=10.1378/chest.06-1355&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="element-citation">Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casorali P, Caramori G, Fabbri LM, Johnston SL. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>2006;<span class="ref-vol">173</span>:1114\xe2\x80\x931121. doi: 10.1164/rccm.200506-859OC.</span> [<a href="/pubmed/16484677" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Frccm.200506-859OC" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=Infections+and+airway+inflammation+in+chronic+obstructive+pulmonary+disease+severe+exacerbations&amp;author=A+Papi&amp;author=CM+Bellettato&amp;author=F+Braccioni&amp;author=M+Romagnoli&amp;author=P+Casorali&amp;volume=173&amp;publication_year=2006&amp;pages=1114-1121&amp;pmid=16484677&amp;doi=10.1164/rccm.200506-859OC&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Ko FW, Ip M, Chan PK, Chan MC, To KW, Ng SS, Chau SS, Tang JW, Hui DS. Viral etiology of acute exacerbations of COPD in Hong Kong. <span><span class="ref-journal">Chest. </span>2007;<span class="ref-vol">132</span>:900\xe2\x80\x93908. doi: 10.1378/chest.07-0530.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7094736/">PMC free article</a>]</span> [<a href="/pubmed/17573516" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1378%2Fchest.07-0530" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=Viral+etiology+of+acute+exacerbations+of+COPD+in+Hong+Kong&amp;author=FW+Ko&amp;author=M+Ip&amp;author=PK+Chan&amp;author=MC+Chan&amp;author=KW+To&amp;volume=132&amp;publication_year=2007&amp;pages=900-908&amp;pmid=17573516&amp;doi=10.1378/chest.07-0530&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32">32. <span class="element-citation">Wilkinson TM, Hurst JR, Perera WR, Wilks M, Donaldson GC, Wedzicha JA. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of. <span><span class="ref-journal">Chest. </span>2006;<span class="ref-vol">129</span>:223\xe2\x80\x93224. doi: 10.1378/chest.129.2.317.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7094441/">PMC free article</a>]</span> [<a href="/pubmed/16478847" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1378%2Fchest.129.2.317" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=Effect+of+interactions+between+lower+airway+bacterial+and+rhinoviral+infection+in+exacerbations+of&amp;author=TM+Wilkinson&amp;author=JR+Hurst&amp;author=WR+Perera&amp;author=M+Wilks&amp;author=GC+Donaldson&amp;volume=129&amp;publication_year=2006&amp;pages=223-224&amp;pmid=16478834&amp;doi=10.1378/chest.129.2.317&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR33">33. <span class="element-citation">Stolz D, Christ-Crain M, Morgenthaler NG, Leuppi J, Miedinger D, Bingisser R, M&#x000fc;ller C, Struck J, M&#x000fc;ller B, Tamm M. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. <span><span class="ref-journal">Chest. </span>2007;<span class="ref-vol">131</span>:1058\xe2\x80\x931067. doi: 10.1378/chest.06-2336.</span> [<a href="/pubmed/17426210" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1378%2Fchest.06-2336" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=Copeptin,+C-reactive+protein,+and+procalcitonin+as+prognostic+biomarkers+in+acute+exacerbation+of+COPD&amp;author=D+Stolz&amp;author=M+Christ-Crain&amp;author=NG+Morgenthaler&amp;author=J+Leuppi&amp;author=D+Miedinger&amp;volume=131&amp;publication_year=2007&amp;pages=1058-1067&amp;pmid=17426210&amp;doi=10.1378/chest.06-2336&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR34">34. <span class="element-citation">Stockley RA, O\'Brien C, Pye A, Hill SL. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. <span><span class="ref-journal">Chest. </span>2000;<span class="ref-vol">117</span>:1638\xe2\x80\x931645. doi: 10.1378/chest.117.6.1638.</span> [<a href="/pubmed/10858396" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1378%2Fchest.117.6.1638" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=Relationship+of+sputum+color+to+nature+and+outpatient+management+of+acute+exacerbations+of+COPD&amp;author=RA+Stockley&amp;author=C+O\'Brien&amp;author=A+Pye&amp;author=SL+Hill&amp;volume=117&amp;publication_year=2000&amp;pages=1638-1645&amp;pmid=10858396&amp;doi=10.1378/chest.117.6.1638&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR35">35. <span class="element-citation">Rosell A, Mons&#x000f3; E, Soler N, Torres F, Angrill J, Riise G, Zalaca&#x000ed;n R, Morera J, Torres A. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. <span><span class="ref-journal">Arch Intern Med. </span>2005;<span class="ref-vol">165</span>:891\xe2\x80\x93897. doi: 10.1001/archinte.165.8.891.</span> [<a href="/pubmed/15851640" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1001%2Farchinte.165.8.891" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Intern+Med&amp;title=Microbiologic+determinants+of+exacerbation+in+chronic+obstructive+pulmonary+disease&amp;author=A+Rosell&amp;author=E+Mons&#x000f3;&amp;author=N+Soler&amp;author=F+Torres&amp;author=J+Angrill&amp;volume=165&amp;publication_year=2005&amp;pages=891-897&amp;pmid=15851640&amp;doi=10.1001/archinte.165.8.891&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR36">36. <span class="element-citation">Clec\'h C, Fosse JP, Karoubi P, Vincent F, Chouahi I, Hamza L, Cupa M, Cohen Y. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. <span><span class="ref-journal">Crit Care Med. </span>2006;<span class="ref-vol">34</span>:102\xe2\x80\x93107. doi: 10.1097/01.CCM.0000195012.54682.F3.</span> [<a href="/pubmed/16374163" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1097%2F01.CCM.0000195012.54682.F3" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Care+Med&amp;title=Differential+diagnostic+value+of+procalcitonin+in+surgical+and+medical+patients+with+septic+shock&amp;author=C+Clec\'h&amp;author=JP+Fosse&amp;author=P+Karoubi&amp;author=F+Vincent&amp;author=I+Chouahi&amp;volume=34&amp;publication_year=2006&amp;pages=102-107&amp;pmid=16374163&amp;doi=10.1097/01.CCM.0000195012.54682.F3&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR37">37. <span class="element-citation">Luyt CE, Gu&#x000e9;rin V, Combes A, Trouillet JL, Ayed SB, Bernard M, Gibert C, Chastre J. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>2005;<span class="ref-vol">171</span>:48\xe2\x80\x9353. doi: 10.1164/rccm.200406-746OC.</span> [<a href="/pubmed/15447947" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Frccm.200406-746OC" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=Procalcitonin+kinetics+as+a+prognostic+marker+of+ventilator-associated+pneumonia&amp;author=CE+Luyt&amp;author=V+Gu&#x000e9;rin&amp;author=A+Combes&amp;author=JL+Trouillet&amp;author=SB+Ayed&amp;volume=171&amp;publication_year=2005&amp;pages=48-53&amp;pmid=15447947&amp;doi=10.1164/rccm.200406-746OC&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR38">38. <span class="element-citation">Puhan MA, Vollenweider D, Latshang T, Steurer J, Steurer-Stey C. Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review. <span><span class="ref-journal">Respir Res. </span>2007;<span class="ref-vol">4</span>(8):30. doi: 10.1186/1465-9921-8-30.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1853091/">PMC free article</a>]</span> [<a href="/pubmed/17407610" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2F1465-9921-8-30" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Respir+Res&amp;title=Exacerbations+of+chronic+obstructive+pulmonary+disease:+when+are+antibiotics+indicated?+A+systematic+review&amp;author=MA+Puhan&amp;author=D+Vollenweider&amp;author=T+Latshang&amp;author=J+Steurer&amp;author=C+Steurer-Stey&amp;volume=4&amp;issue=8&amp;publication_year=2007&amp;pages=30&amp;doi=10.1186/1465-9921-8-30&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR39">39. <span class="element-citation">Martinez FJ, Curtis JL. Procalcitonin-guided antibiotic therapy in COPD exacerbations: closer but not quite there. <span><span class="ref-journal">Chest. </span>2007;<span class="ref-vol">131</span>:1\xe2\x80\x932. doi: 10.1378/chest.06-2567.</span> [<a href="/pubmed/17218546" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1378%2Fchest.06-2567" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=Procalcitonin-guided+antibiotic+therapy+in+COPD+exacerbations:+closer+but+not+quite+there&amp;author=FJ+Martinez&amp;author=JL+Curtis&amp;volume=131&amp;publication_year=2007&amp;pages=1-2&amp;pmid=17218546&amp;doi=10.1378/chest.06-2567&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR40">40. <span class="element-citation">Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>2000;<span class="ref-vol">162</span>:505\xe2\x80\x93511. doi: 10.1164/ajrccm.162.2.9909095.</span> [<a href="/pubmed/10934078" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Fajrccm.162.2.9909095" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=Short-course+empiric+antibiotic+therapy+for+patients+with+pulmonary+infiltrates+in+the+intensive+care+unit.+A+proposed+solution+for+indiscriminate+antibiotic+prescription&amp;author=N+Singh&amp;author=P+Rogers&amp;author=CW+Atwood&amp;author=MM+Wagener&amp;author=VL+Yu&amp;volume=162&amp;publication_year=2000&amp;pages=505-511&amp;pmid=10934078&amp;doi=10.1164/ajrccm.162.2.9909095&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div><div class="ref-list-sec sec" id="BSec1"><h2 id="BSec1title">Pre-publication history</h2><ul class="back-ref-list" style="list-style-type:decimal;"><li id="CR41"><span class="mixed-citation">The pre-publication history for this paper can be accessed here:<a href="http://www.biomedcentral.com/1471-2334/8/145/prepub" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2577677&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.biomedcentral.com/1471-2334/8/145/prepub</a></span></li></ul></div></div></div><!--post-content--></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2577677/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2577677/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2577677/pdf/12879_2008_Article_736.pdf">PDF (506K)</a></li> | <li><a href="#" data-citationid="PMC2577677" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2577677%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2577677%2F&amp;text=Procalcitonin%20levels%20in%20acute%20exacerbation%20of%20COPD%20admitted%20in%20ICU%3A%20a%20prospective%20cohort%20study"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2577677%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="18947382" data-aiid="7091074" data-aid="2577677" data-iid="354737" data-domainid="3814" data-domain="phenaturepg" data-accid="PMC2577677" data-md5="16288d3bbc69bb6edd0ae1c3d0ab3b23"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:57:17-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1BD1AEE99B0B410000000003260326&amp;ncbi_session=8A1BD1AEE99B5BD1_0806SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2577677%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=phenaturepg&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2577677/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1BD1AEE99B5BD1_0806SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'